In light of clinical trials suggesting no benefit from the medication among breast cancer patients, U.S. Food and Drug Administration advisory panel voted yesterday in favor of withdrawing approval of the cancer drug Avastin (bevacizumab) for treatment of breast cancer. Avastin, which is manufactured by Roche, was originally granted
…
A new analysis published in the Journal of the American Society of Nephrology finds that a drug commonly used for cancer treatment may cause kidney damage in some patients. The drug, bevacizumab, is approved by the U.S. Food and Drug Administration for treating glioblastoma brain tumors, metastasized breast cancer and other forms of
…
While chemotherapy is often a critical component of cancer treatment, its side effects—which can include hair loss, loss of appetite, nausea, vomiting and new infections, among other health problems—are often debilitating and painful. Adding to previous findings suggesting that fasting prior to chemo might help decrease side effects,
…
